256 Newsroom — Uganda's Digital News Infrastructure
Health

Study Shows Rapid Reversal of Autism Traits - Neuroscience News

Share
Study Shows Rapid Reversal of Autism Traits - Neuroscience News
Image · Neurosciencenews.com

What the report says

Neuroscience News reported on a UCLA Health-led mouse study finding that autism-like brain and behavior changes linked to inflammation during pregnancy could be rapidly, but temporarily, eased in adult offspring. The study, published in Nature Communications, used a maternal immune activation model in which pregnant mice were exposed to a mild inflammatory trigger early in gestation. Their offspring later showed chronic inflammation, mild brain overgrowth, heightened sensory responses, disorganized functional brain connectivity, seizure susceptibility and repetitive behaviors.

According to the report, researchers gave the adult offspring a single dose of rapamycin, an immunosuppressive drug known to inhibit the mTOR cell-signaling pathway. Within roughly two hours, abnormal neuronal firing decreased, seizure susceptibility fell, brain network activity became more typical, and some repetitive and sensory-related behaviors improved. The short timeframe was central to the interpretation: it suggested the changes were driven by rapid functional shifts in neuronal excitability and circuit activity, rather than by repair of structural brain differences formed during development.

The researchers also analyzed gene activity and found that rapamycin quickly altered abnormal expression patterns involving autism-, epilepsy- and ion-channel-related genes, especially in excitatory neurons. Neuroscience News reported that the authors view these findings as evidence that the adult brain may retain more functional adaptability than previously assumed, even when developmental structural differences remain.

The study does not support rapamycin as an autism treatment for people. The reported effects were temporary, repeated dosing led to tolerance in mice, and rapamycin can carry toxicity risks. The authors instead pointed to possible future treatment directions involving mTOR-related signaling, neuronal excitation-inhibition balance, sensory circuits and brain network modulation.

Read the full report at Neurosciencenews.com →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting